Loading…

NaCl: for the safer in vivo use of antibacterial silver based nanoparticles

As antibiotics progressively cease to be effective, silver based nanoparticles (SBNs), with broad antibacterial spectrum, might be the last line of defense against malicious bacteria. Unfortunately, there are still no proper SBNs-based strategies for in vivo antibacterial therapies. In this article,...

Full description

Saved in:
Bibliographic Details
Published in:International journal of nanomedicine 2018-01, Vol.13, p.1737-1748
Main Authors: Liu, Mingzhuo, Zhang, Huiqing, Song, Xiangwei, Wei, Chaochao, Xiong, Zhenfang, Yu, Fen, Li, Chen, Ai, Fanrong, Guo, Guanghua, Wang, Xiaolei
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c542t-eb21172e46bb9ae8059fef957978384f0f0a7efca8580df371dd818ce1088d5e3
cites
container_end_page 1748
container_issue
container_start_page 1737
container_title International journal of nanomedicine
container_volume 13
creator Liu, Mingzhuo
Zhang, Huiqing
Song, Xiangwei
Wei, Chaochao
Xiong, Zhenfang
Yu, Fen
Li, Chen
Ai, Fanrong
Guo, Guanghua
Wang, Xiaolei
description As antibiotics progressively cease to be effective, silver based nanoparticles (SBNs), with broad antibacterial spectrum, might be the last line of defense against malicious bacteria. Unfortunately, there are still no proper SBNs-based strategies for in vivo antibacterial therapies. In this article, new carbon membrane packaged Ag nanoparticles (Ag-C) were synthesized. We assessed the effect of Ag-C with NaCl on size, cytotoxicity, antibacterial properties, metabolism and sepsis models. The size of Ag-C with NaCl was accessed with UV-vis, TEM and SEM. , and were used to illustrate the antibacterial properties of SBNs affected by NaCl. L929 and 3T3 cell lines were cultured in vitro; CCK-8 assay was used to test cytotoxicity. Then, we explored the metabolism of Ag-C with NaCl in vivo. Finally, the effect of Ag-C with 4× NaCl on sepsis was observed. NaCl could regulate the size of Ag-C. Ag-C exhibited superior antibacterial properties compared to similar sized pure Ag nanoparticles. Furthermore, the addition of NaCl could not only reduce the cytotoxicity of Ag-C, but could also continue to discharge Ag-C from major organs. Based on these factors, this method was used to treat a sepsis model (induced via cecal ligation and puncture), and it achieved satisfactory survival results. This discovery, though still in its infancy, could significantly improve the safety and feasibility of SBNs and could potentially play an important role in modern in vivo antibacterial applications. Thus, a new method to combating the growing threat from drug-resistant bacteria could be possible. NaCl is the key to excretion of SBNs after in vivo antibacterial use.
doi_str_mv 10.2147/IJN.S153168
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_6098b11cfbf8487f9bc94d6611ac9ba6</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A583487828</galeid><doaj_id>oai_doaj_org_article_6098b11cfbf8487f9bc94d6611ac9ba6</doaj_id><sourcerecordid>A583487828</sourcerecordid><originalsourceid>FETCH-LOGICAL-c542t-eb21172e46bb9ae8059fef957978384f0f0a7efca8580df371dd818ce1088d5e3</originalsourceid><addsrcrecordid>eNptks1vEzEQxVcIREvhxB1Z4lgl2Ou1PeaAVEV8BKpyAM6W7R2njjbrYG8i8d_jklAaCc3Bo_Gbn95Ir2leMjpvWafeLD_fzL8xwZmER805YwpmLWX88YP-rHlWyppSoUDqp81ZqyWVINV58-XGLoa3JKRMplskxQbMJI5kH_eJ7AqSFIgdp-isnzBHO5ASh33VOFuwJ6Md09bmKfoBy_PmSbBDwRfH96L58eH998Wn2fXXj8vF1fXMi66dZujaaqzFTjqnLQIVOmDQQmkFHLpAA7UKg7cggPaBK9b3wMAjowC9QH7RLA_cPtm12ea4sfmXSTaaP4OUV-ZoyUiqwTHmgwvQgQraed31UjJmvXZWVta7A2u7cxvsPY5TtsMJ9PRnjLdmlfZGgAShRAW8PgJy-rnDMpl12uWx3m_aloPkgnL4p1rZ6iqOIVWY38TizZUAXq1Be6ea_0dVq8dN9GnEEOv8ZOHysOBzKiVjuDfOqLkLh6nhMMdwVPWrh7fea_-mgf8GxfazhA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2238635038</pqid></control><display><type>article</type><title>NaCl: for the safer in vivo use of antibacterial silver based nanoparticles</title><source>PubMed Central (Open Access)</source><source>Taylor &amp; Francis Open Access</source><source>Publicly Available Content (ProQuest)</source><creator>Liu, Mingzhuo ; Zhang, Huiqing ; Song, Xiangwei ; Wei, Chaochao ; Xiong, Zhenfang ; Yu, Fen ; Li, Chen ; Ai, Fanrong ; Guo, Guanghua ; Wang, Xiaolei</creator><creatorcontrib>Liu, Mingzhuo ; Zhang, Huiqing ; Song, Xiangwei ; Wei, Chaochao ; Xiong, Zhenfang ; Yu, Fen ; Li, Chen ; Ai, Fanrong ; Guo, Guanghua ; Wang, Xiaolei</creatorcontrib><description>As antibiotics progressively cease to be effective, silver based nanoparticles (SBNs), with broad antibacterial spectrum, might be the last line of defense against malicious bacteria. Unfortunately, there are still no proper SBNs-based strategies for in vivo antibacterial therapies. In this article, new carbon membrane packaged Ag nanoparticles (Ag-C) were synthesized. We assessed the effect of Ag-C with NaCl on size, cytotoxicity, antibacterial properties, metabolism and sepsis models. The size of Ag-C with NaCl was accessed with UV-vis, TEM and SEM. , and were used to illustrate the antibacterial properties of SBNs affected by NaCl. L929 and 3T3 cell lines were cultured in vitro; CCK-8 assay was used to test cytotoxicity. Then, we explored the metabolism of Ag-C with NaCl in vivo. Finally, the effect of Ag-C with 4× NaCl on sepsis was observed. NaCl could regulate the size of Ag-C. Ag-C exhibited superior antibacterial properties compared to similar sized pure Ag nanoparticles. Furthermore, the addition of NaCl could not only reduce the cytotoxicity of Ag-C, but could also continue to discharge Ag-C from major organs. Based on these factors, this method was used to treat a sepsis model (induced via cecal ligation and puncture), and it achieved satisfactory survival results. This discovery, though still in its infancy, could significantly improve the safety and feasibility of SBNs and could potentially play an important role in modern in vivo antibacterial applications. Thus, a new method to combating the growing threat from drug-resistant bacteria could be possible. NaCl is the key to excretion of SBNs after in vivo antibacterial use.</description><identifier>ISSN: 1178-2013</identifier><identifier>ISSN: 1176-9114</identifier><identifier>EISSN: 1178-2013</identifier><identifier>DOI: 10.2147/IJN.S153168</identifier><identifier>PMID: 29606867</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>Ag nanoparticles ; Animals ; Anti-Bacterial Agents - chemistry ; Anti-Bacterial Agents - pharmacology ; Antibacterial ; Antibacterial agents ; Antibiotics ; Bacteremia - drug therapy ; Bacteremia - microbiology ; Bacteria ; Bone surgery ; Carbon ; Cytotoxcity ; Drug resistance ; Escherichia coli ; Escherichia coli - drug effects ; Gene expression ; Halides ; Hospitals ; Infection ; Male ; Metabolism ; Metal Nanoparticles - administration &amp; dosage ; Metal Nanoparticles - chemistry ; Mice ; Microbial Sensitivity Tests ; Microscopy ; Microscopy, Electron, Scanning ; NaCl ; Nanoparticles ; Original Research ; Particle Size ; Pseudomonas aeruginosa ; Pseudomonas aeruginosa - drug effects ; Silver ; Silver - chemistry ; Silver - pharmacology ; Sodium chloride ; Sodium Chloride - chemistry ; Sodium Chloride - pharmacology ; Spectrophotometry, Ultraviolet ; Staphylococcal Infections ; Staphylococcus aureus ; Staphylococcus aureus - drug effects ; Staphylococcus aureus infections ; Ultrasonic imaging</subject><ispartof>International journal of nanomedicine, 2018-01, Vol.13, p.1737-1748</ispartof><rights>COPYRIGHT 2018 Dove Medical Press Limited</rights><rights>2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2018 Liu et al. This work is published and licensed by Dove Medical Press Limited 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c542t-eb21172e46bb9ae8059fef957978384f0f0a7efca8580df371dd818ce1088d5e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2238635038/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2238635038?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29606867$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Mingzhuo</creatorcontrib><creatorcontrib>Zhang, Huiqing</creatorcontrib><creatorcontrib>Song, Xiangwei</creatorcontrib><creatorcontrib>Wei, Chaochao</creatorcontrib><creatorcontrib>Xiong, Zhenfang</creatorcontrib><creatorcontrib>Yu, Fen</creatorcontrib><creatorcontrib>Li, Chen</creatorcontrib><creatorcontrib>Ai, Fanrong</creatorcontrib><creatorcontrib>Guo, Guanghua</creatorcontrib><creatorcontrib>Wang, Xiaolei</creatorcontrib><title>NaCl: for the safer in vivo use of antibacterial silver based nanoparticles</title><title>International journal of nanomedicine</title><addtitle>Int J Nanomedicine</addtitle><description>As antibiotics progressively cease to be effective, silver based nanoparticles (SBNs), with broad antibacterial spectrum, might be the last line of defense against malicious bacteria. Unfortunately, there are still no proper SBNs-based strategies for in vivo antibacterial therapies. In this article, new carbon membrane packaged Ag nanoparticles (Ag-C) were synthesized. We assessed the effect of Ag-C with NaCl on size, cytotoxicity, antibacterial properties, metabolism and sepsis models. The size of Ag-C with NaCl was accessed with UV-vis, TEM and SEM. , and were used to illustrate the antibacterial properties of SBNs affected by NaCl. L929 and 3T3 cell lines were cultured in vitro; CCK-8 assay was used to test cytotoxicity. Then, we explored the metabolism of Ag-C with NaCl in vivo. Finally, the effect of Ag-C with 4× NaCl on sepsis was observed. NaCl could regulate the size of Ag-C. Ag-C exhibited superior antibacterial properties compared to similar sized pure Ag nanoparticles. Furthermore, the addition of NaCl could not only reduce the cytotoxicity of Ag-C, but could also continue to discharge Ag-C from major organs. Based on these factors, this method was used to treat a sepsis model (induced via cecal ligation and puncture), and it achieved satisfactory survival results. This discovery, though still in its infancy, could significantly improve the safety and feasibility of SBNs and could potentially play an important role in modern in vivo antibacterial applications. Thus, a new method to combating the growing threat from drug-resistant bacteria could be possible. NaCl is the key to excretion of SBNs after in vivo antibacterial use.</description><subject>Ag nanoparticles</subject><subject>Animals</subject><subject>Anti-Bacterial Agents - chemistry</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibacterial</subject><subject>Antibacterial agents</subject><subject>Antibiotics</subject><subject>Bacteremia - drug therapy</subject><subject>Bacteremia - microbiology</subject><subject>Bacteria</subject><subject>Bone surgery</subject><subject>Carbon</subject><subject>Cytotoxcity</subject><subject>Drug resistance</subject><subject>Escherichia coli</subject><subject>Escherichia coli - drug effects</subject><subject>Gene expression</subject><subject>Halides</subject><subject>Hospitals</subject><subject>Infection</subject><subject>Male</subject><subject>Metabolism</subject><subject>Metal Nanoparticles - administration &amp; dosage</subject><subject>Metal Nanoparticles - chemistry</subject><subject>Mice</subject><subject>Microbial Sensitivity Tests</subject><subject>Microscopy</subject><subject>Microscopy, Electron, Scanning</subject><subject>NaCl</subject><subject>Nanoparticles</subject><subject>Original Research</subject><subject>Particle Size</subject><subject>Pseudomonas aeruginosa</subject><subject>Pseudomonas aeruginosa - drug effects</subject><subject>Silver</subject><subject>Silver - chemistry</subject><subject>Silver - pharmacology</subject><subject>Sodium chloride</subject><subject>Sodium Chloride - chemistry</subject><subject>Sodium Chloride - pharmacology</subject><subject>Spectrophotometry, Ultraviolet</subject><subject>Staphylococcal Infections</subject><subject>Staphylococcus aureus</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Staphylococcus aureus infections</subject><subject>Ultrasonic imaging</subject><issn>1178-2013</issn><issn>1176-9114</issn><issn>1178-2013</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNptks1vEzEQxVcIREvhxB1Z4lgl2Ou1PeaAVEV8BKpyAM6W7R2njjbrYG8i8d_jklAaCc3Bo_Gbn95Ir2leMjpvWafeLD_fzL8xwZmER805YwpmLWX88YP-rHlWyppSoUDqp81ZqyWVINV58-XGLoa3JKRMplskxQbMJI5kH_eJ7AqSFIgdp-isnzBHO5ASh33VOFuwJ6Md09bmKfoBy_PmSbBDwRfH96L58eH998Wn2fXXj8vF1fXMi66dZujaaqzFTjqnLQIVOmDQQmkFHLpAA7UKg7cggPaBK9b3wMAjowC9QH7RLA_cPtm12ea4sfmXSTaaP4OUV-ZoyUiqwTHmgwvQgQraed31UjJmvXZWVta7A2u7cxvsPY5TtsMJ9PRnjLdmlfZGgAShRAW8PgJy-rnDMpl12uWx3m_aloPkgnL4p1rZ6iqOIVWY38TizZUAXq1Be6ea_0dVq8dN9GnEEOv8ZOHysOBzKiVjuDfOqLkLh6nhMMdwVPWrh7fea_-mgf8GxfazhA</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>Liu, Mingzhuo</creator><creator>Zhang, Huiqing</creator><creator>Song, Xiangwei</creator><creator>Wei, Chaochao</creator><creator>Xiong, Zhenfang</creator><creator>Yu, Fen</creator><creator>Li, Chen</creator><creator>Ai, Fanrong</creator><creator>Guo, Guanghua</creator><creator>Wang, Xiaolei</creator><general>Dove Medical Press Limited</general><general>Taylor &amp; Francis Ltd</general><general>Dove Medical Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>20180101</creationdate><title>NaCl: for the safer in vivo use of antibacterial silver based nanoparticles</title><author>Liu, Mingzhuo ; Zhang, Huiqing ; Song, Xiangwei ; Wei, Chaochao ; Xiong, Zhenfang ; Yu, Fen ; Li, Chen ; Ai, Fanrong ; Guo, Guanghua ; Wang, Xiaolei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c542t-eb21172e46bb9ae8059fef957978384f0f0a7efca8580df371dd818ce1088d5e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Ag nanoparticles</topic><topic>Animals</topic><topic>Anti-Bacterial Agents - chemistry</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibacterial</topic><topic>Antibacterial agents</topic><topic>Antibiotics</topic><topic>Bacteremia - drug therapy</topic><topic>Bacteremia - microbiology</topic><topic>Bacteria</topic><topic>Bone surgery</topic><topic>Carbon</topic><topic>Cytotoxcity</topic><topic>Drug resistance</topic><topic>Escherichia coli</topic><topic>Escherichia coli - drug effects</topic><topic>Gene expression</topic><topic>Halides</topic><topic>Hospitals</topic><topic>Infection</topic><topic>Male</topic><topic>Metabolism</topic><topic>Metal Nanoparticles - administration &amp; dosage</topic><topic>Metal Nanoparticles - chemistry</topic><topic>Mice</topic><topic>Microbial Sensitivity Tests</topic><topic>Microscopy</topic><topic>Microscopy, Electron, Scanning</topic><topic>NaCl</topic><topic>Nanoparticles</topic><topic>Original Research</topic><topic>Particle Size</topic><topic>Pseudomonas aeruginosa</topic><topic>Pseudomonas aeruginosa - drug effects</topic><topic>Silver</topic><topic>Silver - chemistry</topic><topic>Silver - pharmacology</topic><topic>Sodium chloride</topic><topic>Sodium Chloride - chemistry</topic><topic>Sodium Chloride - pharmacology</topic><topic>Spectrophotometry, Ultraviolet</topic><topic>Staphylococcal Infections</topic><topic>Staphylococcus aureus</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Staphylococcus aureus infections</topic><topic>Ultrasonic imaging</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Mingzhuo</creatorcontrib><creatorcontrib>Zhang, Huiqing</creatorcontrib><creatorcontrib>Song, Xiangwei</creatorcontrib><creatorcontrib>Wei, Chaochao</creatorcontrib><creatorcontrib>Xiong, Zhenfang</creatorcontrib><creatorcontrib>Yu, Fen</creatorcontrib><creatorcontrib>Li, Chen</creatorcontrib><creatorcontrib>Ai, Fanrong</creatorcontrib><creatorcontrib>Guo, Guanghua</creatorcontrib><creatorcontrib>Wang, Xiaolei</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of nanomedicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Mingzhuo</au><au>Zhang, Huiqing</au><au>Song, Xiangwei</au><au>Wei, Chaochao</au><au>Xiong, Zhenfang</au><au>Yu, Fen</au><au>Li, Chen</au><au>Ai, Fanrong</au><au>Guo, Guanghua</au><au>Wang, Xiaolei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>NaCl: for the safer in vivo use of antibacterial silver based nanoparticles</atitle><jtitle>International journal of nanomedicine</jtitle><addtitle>Int J Nanomedicine</addtitle><date>2018-01-01</date><risdate>2018</risdate><volume>13</volume><spage>1737</spage><epage>1748</epage><pages>1737-1748</pages><issn>1178-2013</issn><issn>1176-9114</issn><eissn>1178-2013</eissn><abstract>As antibiotics progressively cease to be effective, silver based nanoparticles (SBNs), with broad antibacterial spectrum, might be the last line of defense against malicious bacteria. Unfortunately, there are still no proper SBNs-based strategies for in vivo antibacterial therapies. In this article, new carbon membrane packaged Ag nanoparticles (Ag-C) were synthesized. We assessed the effect of Ag-C with NaCl on size, cytotoxicity, antibacterial properties, metabolism and sepsis models. The size of Ag-C with NaCl was accessed with UV-vis, TEM and SEM. , and were used to illustrate the antibacterial properties of SBNs affected by NaCl. L929 and 3T3 cell lines were cultured in vitro; CCK-8 assay was used to test cytotoxicity. Then, we explored the metabolism of Ag-C with NaCl in vivo. Finally, the effect of Ag-C with 4× NaCl on sepsis was observed. NaCl could regulate the size of Ag-C. Ag-C exhibited superior antibacterial properties compared to similar sized pure Ag nanoparticles. Furthermore, the addition of NaCl could not only reduce the cytotoxicity of Ag-C, but could also continue to discharge Ag-C from major organs. Based on these factors, this method was used to treat a sepsis model (induced via cecal ligation and puncture), and it achieved satisfactory survival results. This discovery, though still in its infancy, could significantly improve the safety and feasibility of SBNs and could potentially play an important role in modern in vivo antibacterial applications. Thus, a new method to combating the growing threat from drug-resistant bacteria could be possible. NaCl is the key to excretion of SBNs after in vivo antibacterial use.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>29606867</pmid><doi>10.2147/IJN.S153168</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1178-2013
ispartof International journal of nanomedicine, 2018-01, Vol.13, p.1737-1748
issn 1178-2013
1176-9114
1178-2013
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_6098b11cfbf8487f9bc94d6611ac9ba6
source PubMed Central (Open Access); Taylor & Francis Open Access; Publicly Available Content (ProQuest)
subjects Ag nanoparticles
Animals
Anti-Bacterial Agents - chemistry
Anti-Bacterial Agents - pharmacology
Antibacterial
Antibacterial agents
Antibiotics
Bacteremia - drug therapy
Bacteremia - microbiology
Bacteria
Bone surgery
Carbon
Cytotoxcity
Drug resistance
Escherichia coli
Escherichia coli - drug effects
Gene expression
Halides
Hospitals
Infection
Male
Metabolism
Metal Nanoparticles - administration & dosage
Metal Nanoparticles - chemistry
Mice
Microbial Sensitivity Tests
Microscopy
Microscopy, Electron, Scanning
NaCl
Nanoparticles
Original Research
Particle Size
Pseudomonas aeruginosa
Pseudomonas aeruginosa - drug effects
Silver
Silver - chemistry
Silver - pharmacology
Sodium chloride
Sodium Chloride - chemistry
Sodium Chloride - pharmacology
Spectrophotometry, Ultraviolet
Staphylococcal Infections
Staphylococcus aureus
Staphylococcus aureus - drug effects
Staphylococcus aureus infections
Ultrasonic imaging
title NaCl: for the safer in vivo use of antibacterial silver based nanoparticles
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T00%3A18%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=NaCl:%20for%20the%20safer%20in%20vivo%20use%20of%20antibacterial%20silver%20based%20nanoparticles&rft.jtitle=International%20journal%20of%20nanomedicine&rft.au=Liu,%20Mingzhuo&rft.date=2018-01-01&rft.volume=13&rft.spage=1737&rft.epage=1748&rft.pages=1737-1748&rft.issn=1178-2013&rft.eissn=1178-2013&rft_id=info:doi/10.2147/IJN.S153168&rft_dat=%3Cgale_doaj_%3EA583487828%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c542t-eb21172e46bb9ae8059fef957978384f0f0a7efca8580df371dd818ce1088d5e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2238635038&rft_id=info:pmid/29606867&rft_galeid=A583487828&rfr_iscdi=true